Literature DB >> 11727173

Successful use of oral contraceptives.

A E Burke1, P D Blumenthal.   

Abstract

Typical failure rates for oral contraceptives remain much higher than ideal failure rates. Patients can cite the pill's perceived risks more readily than its benefits, and many women use oral contraceptives inconsistently or discontinue them entirely without a medical reason. Successful use of oral contraceptives mandates that we rethink our roles as providers. Medical barriers, such as mandatory pelvic examinations, impede clients' access to services and require reevaluation. Efforts must also focus on thorough, individualized counseling. Because compliance poses difficulties for many women and noncompliance results in reduced efficacy, counseling must address content points relevant to proper, consistent use. Additionally, as unexpected side effects often cause frustration and method discontinuation, counseling should anticipate their occurrence. Adolescents present additional challenges. However, with careful attention to concerns relevant to teenage women and consideration of obstacles to compliance, oral contraceptives can indeed be used successfully in this group. Regardless of age, all clients should receive information regarding emergency contraception, and instructions for pill use should be individualized to meet the needs of each patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727173     DOI: 10.1055/s-2001-18639

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  1 in total

1.  Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.

Authors:  Fan Guang-Sheng; Bian Mei-Lu; Cheng Li-Nan; Cao Xiao-Ming; Huang Zi-Rong; Han Zi-Yan; Jing Xiao-Ping; Li Jian; Wu Shu-Ying; Xiong Cheng-Liang; Xiong Zheng-Ai; Yue Tian-Fu
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.